Citations (54)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Rikke Hjortebjerg, Allan Flyvbjerg & Jan Frystyk. (2014) Insulin growth factor binding proteins as therapeutic targets in type 2 diabetes. Expert Opinion on Therapeutic Targets 18:2, pages 209-224.
Read now
Read now
Afroze Abbas, Peter J Grant & Mark T Kearney. (2008) Role of IGF-1 in glucose regulation and cardiovascular disease. Expert Review of Cardiovascular Therapy 6:8, pages 1135-1149.
Read now
Read now
Gun E. Sandberg & Karin F. Wikblad. (2003) Oral health and health-related quality of life in type 2 diabetic patients and non-diabetic controls. Acta Odontologica Scandinavica 61:3, pages 141-148.
Read now
Read now
Articles from other publishers (51)
Aldona Kasprzak. (2021) Insulin-Like Growth Factor 1 (IGF-1) Signaling in Glucose Metabolism in Colorectal Cancer. International Journal of Molecular Sciences 22:12, pages 6434.
Crossref
Crossref
Yi X Chan, Helman Alfonso, P Gerry Fegan, Leon Flicker & Bu B Yeap. (2019) Neither Hormonal Factors Nor AGEs Explain Lower Prostate Cancer Risk in Older Men With Diabetes Mellitus. The Journal of Clinical Endocrinology & Metabolism 104:12, pages 6017-6024.
Crossref
Crossref
M. Kallestrup, J. Frystyk, U. Espelund, R. Hjortebjerg, H. Tankisi & H. Andersen. (2019) PAPP-A activity is increased in cerebrospinal fluid from patients with diabetic polyneuropathy and correlates with peripheral nerve impairment. Growth Hormone & IGF Research 48-49, pages 53-59.
Crossref
Crossref
Xi-Rui Wang, Wen-Juan Wang, Xiaodan Yu, Xiaolin Hua, Fengxiu Ouyang & Zhong-Cheng Luo. (2019) Insulin-Like Growth Factor Axis Biomarkers and Gestational Diabetes Mellitus: A Systematic Review and Meta-Analysis. Frontiers in Endocrinology 10.
Crossref
Crossref
Ileana Ruxandra Botusan, Xiaowei Zheng, Sampath Narayanan, Jacob Grünler, Vivekananda Gupta Sunkari, Freja S. Calissendorff, Ishrath Ansurudeen, Christopher Illies, Johan Svensson, John-Olov Jansson, Claes Ohlsson, Kerstin Brismar & Sergiu-Bogdan Catrina. (2018) Deficiency of liver-derived insulin-like growth factor-I (IGF-I) does not interfere with the skin wound healing rate. PLOS ONE 13:3, pages e0193084.
Crossref
Crossref
Soner CanderOzen Oz GulOguzhan Sitki DizdarNizameddin KocaTaner AydınEmre SarandolCanan Ersoy. (2017) Assessing the Impact of Insulin Glargine and Detemir Treatment to Serum Total IGF1 Levels in the Insulin-Naive Type 2 Diabetic Patients. Metabolic Syndrome and Related Disorders 15:5, pages 220-225.
Crossref
Crossref
Rikke Hjortebjerg, Esben Laugesen, Pernille Høyem, Claus Oxvig, Brian Stausbøl-Grøn, Søren T Knudsen, Won Y Kim, Per L Poulsen, Troels K Hansen, Mette Bjerre & Jan Frystyk. (2017) The IGF system in patients with type 2 diabetes: associations with markers of cardiovascular target organ damage. European Journal of Endocrinology 176:5, pages 521-531.
Crossref
Crossref
Agnieszka Olszanecka, Aneta Dragan, Kalina Kawecka-Jaszcz, Danuta Fedak & Danuta Czarnecka. (2017) Relationships of insulin-like growth factor-1, its binding proteins, and cardiometabolic risk in hypertensive perimenopausal women. Metabolism 69, pages 96-106.
Crossref
Crossref
Guanjie Chen, Zhenjian Zhang, Sally N. Adebamowo, Guozheng Liu, Adebowale Adeyemo, Yanxun Zhou, Ayo P. Doumatey, Chuntao Wang, Jie Zhou, Wenqiang Yan, Daniel Shriner, Fasil Tekola-Ayele, Amy R. Bentley, Congqing Jiang & Charles N. Rotimi. (2017) Common and rare exonic MUC5B variants associated with type 2 diabetes in Han Chinese. PLOS ONE 12:3, pages e0173784.
Crossref
Crossref
Alexander O Shpakov, Kira V Derkach & Lev M Berstein. (2015) Brain signaling systems in the Type 2 diabetes and metabolic syndrome: promising target to treat and prevent these diseases. Future Science OA 1:3.
Crossref
Crossref
Elisabete A Forsberg, Ileana R Botusan, Jing Wang, Verena Peters, Ishrath Ansurudeen, Kerstin Brismar & Sergiu Bogdan Catrina. (2015) Carnosine decreases IGFBP1 production in db/db mice through suppression of HIF-1. Journal of Endocrinology 225:3, pages 159-167.
Crossref
Crossref
Reza Rastmanesh, Jalal Hejazi, Francesco Marotta & Noboru Hara. (2014) Type 2 Diabetes: A Protective Factor for Prostate Cancer? An Overview of Proposed Mechanisms. Clinical Genitourinary Cancer 12:3, pages 143-148.
Crossref
Crossref
Ling Oei, M. Carola Zillikens, Abbas Dehghan, Gabriëlle H.S. Buitendijk, Martha C. Castaño-Betancourt, Karol Estrada, Lisette Stolk, Edwin H.G. Oei, Joyce B.J. van Meurs, Joseph A.M.J.L. Janssen, Albert Hofman, Johannes P.T.M. van Leeuwen, Jacqueline C.M. Witteman, Huibert A.P. Pols, André G. Uitterlinden, Caroline C.W. Klaver, Oscar H. Franco & Fernando Rivadeneira. (2013) High Bone Mineral Density and Fracture Risk in Type 2 Diabetes as Skeletal Complications of Inadequate Glucose Control. Diabetes Care 36:6, pages 1619-1628.
Crossref
Crossref
Anna Pawlikowska-Haddal, Pinchas Cohen & David M. Cook. (2011) How useful are serum IGF-I measurements for managing GH replacement therapy in adults and children?. Pituitary 15:2, pages 126-134.
Crossref
Crossref
A. J. Varewijck, J. A. M. J. L. Janssen, M. Vähätalo, L. J. Hofland, S. W. J. Lamberts & H. Yki-Järvinen. (2012) Addition of insulin glargine or NPH insulin to metformin monotherapy in poorly controlled type 2 diabetic patients decreases IGF-I bioactivity similarly. Diabetologia 55:4, pages 1186-1194.
Crossref
Crossref
Carla Lopes, Ana I. Duarte, Michael Hayden & A. Cristina Rego. (2012) Peripheral and cerebral metabolic features in an animal model of Huntington's disease. Peripheral and cerebral metabolic features in an animal model of Huntington's disease.
Frédéric De Ceuninck, Jean-Olivier Rolin, Audrey Caliez, Louise Baschet & Alain Ktorza. (2011) Metabolic imbalance of the insulin-like growth factor–I axis in Zucker diabetic fatty rats. Metabolism 60:11, pages 1575-1583.
Crossref
Crossref
Elena Conti, Maria Beatrice Musumeci, Marco De Giusti, Eleonora Dito, Vittoria Mastromarino, Camillo Autore & Massimo Volpe. (2011) IGF-1 and atherothrombosis: relevance to pathophysiology and therapy. Clinical Science 120:9, pages 377-402.
Crossref
Crossref
Amin Esfahani, Cyril W. C. Kendall, Balachandran Bashyam, Michael C. Archer & David J. A. Jenkins. (2010) The effect of physiological concentrations of sex hormones, insulin, and glucagon on growth of breast and prostate cells supplemented with unmodified human serum. In Vitro Cellular & Developmental Biology - Animal 46:10, pages 856-862.
Crossref
Crossref
Jocelyn S. Kasper, Yan Liu & Edward Giovannucci. (2009) Diabetes mellitus and risk of prostate cancer in the health professionals follow-up study. International Journal of Cancer 124:6, pages 1398-1403.
Crossref
Crossref
Justo Sierra-Johnson, Abel Romero-CorralVirend K. SomersFrancisco Lopez-JimenezAnders Mälarstig, Kerstin Brismar, Anders Hamsten, Rachel M. Fisher & Mai-Lis Hellénius. (2009) IGF-I/IGFBP-3 ratio: a mechanistic insight into the metabolic syndrome. Clinical Science 116:6, pages 507-512.
Crossref
Crossref
Swapnil N. Rajpathak, Marc J. Gunter, Judith Wylie‐Rosett, Gloria Y. F. Ho, Robert C. Kaplan, Radhika Muzumdar, Thomas E. Rohan & Howard D. Strickler. (2009) The role of insulin‐like growth factor‐I and its binding proteins in glucose homeostasis and type 2 diabetes. Diabetes/Metabolism Research and Reviews 25:1, pages 3-12.
Crossref
Crossref
Mikael Lehtihet, Suad Efendic & Kerstin Brismar. (2008) Postprandial paradoxical IGFBP-1 response in obese patients with Type 2 diabetes. Clinical Science 115:5, pages 167-174.
Crossref
Crossref
Jocelyn S. Kasper, Yan Liu, Michael N. Pollak, Nader Rifai & Edward Giovannucci. (2008) Hormonal profile of diabetic men and the potential link to prostate cancer. Cancer Causes & Control 19:7, pages 703-710.
Crossref
Crossref
Marta Bondanelli, Maria Chiara Zatelli, Maria Rosaria Ambrosio & Ettore C. degli Uberti. (2008) Systemic illness. Pituitary 11:2, pages 187-207.
Crossref
Crossref
Vivienne A. Ezzat, Edward R. Duncan, Stephen B. Wheatcroft & Mark T. Kearney. (2008) The role of IGF-I and its binding proteins in the development of type 2 diabetes and cardiovascular disease. Diabetes, Obesity and Metabolism 10:3, pages 198-211.
Crossref
Crossref
Ingeborg Hers. (2007) Insulin-like growth factor-1 potentiates platelet activation via the IRS/PI3Kα pathway. Blood 110:13, pages 4243-4252.
Crossref
Crossref
Mujde Akturk, Metin Arslan, Alev Altinova, Aysegul Ozdemir, Reyhan Ersoy, Ilhan Yetkin, Elif Ayvali, Sevim Gonen & Fusun Toruner. (2007) Association of serum levels of IGF-I and IGFBP-1 with renal function in patients with type 2 diabetes mellitus. Growth Hormone & IGF Research 17:3, pages 186-193.
Crossref
Crossref
Anita Y. M. Kwan & Mark L. Hartman. (2007) IGF-I measurements in the diagnosis of adult growth hormone deficiency. Pituitary 10:2, pages 151-157.
Crossref
Crossref
Fabio Lanfranco, Matteo Baldi, Paola Cassoni, Martino Bosco, Corrado Ghé & Giampiero Muccioli. 2007. Ghrelin. Ghrelin
301
324
.
Jocelyn S. Kasper & Edward Giovannucci. (2006) A Meta-analysis of Diabetes Mellitus and the Risk of Prostate Cancer. Cancer Epidemiology, Biomarkers & Prevention 15:11, pages 2056-2062.
Crossref
Crossref
David R Clemmons. (2006) Clinical utility of measurements of insulin-like growth factor 1. Nature Clinical Practice Endocrinology & Metabolism 2:8, pages 436-446.
Crossref
Crossref
A. Heald, R. Stephens & J. M. Gibson. (2006) The insulin-like growth factor system and diabetes-an overview. Diabetic Medicine 23:s1, pages 19-24.
Crossref
Crossref
Adrienne A. M. Zandbergen, Steven W. J. Lamberts, Marinus G. A. Baggen, Joop A. M. J. L. Janssen, Eric Boersma & Aart H. Bootsma. (2006) The IGF-I system and the renal and haemodynamic effects of losartan in normotensive patients with type 2 diabetes mellitus: a randomized clinical trial. Clinical Endocrinology 64:2, pages 203-208.
Crossref
Crossref
Jan Hammarsten & Benkt Högstedt. (2005) Hyperinsulinaemia: A prospective risk factor for lethal clinical prostate cancer. European Journal of Cancer 41:18, pages 2887-2895.
Crossref
Crossref
Moira S. Lewitt, Kerstin Hall, Peter Bang & Kerstin Brismar. (2005) Altered response of insulin-like growth factor–binding protein 1 to nutritional deprivation in type 2 diabetes mellitus. Metabolism 54:3, pages 275-280.
Crossref
Crossref
Mary F. Carroll & David S. Schade. (2005) The Dawn Phenomenon Revisited: Implications for Diabetes Therapy. Endocrine Practice 11:1, pages 55-64.
Crossref
Crossref
Chi-chen Hong, Henry J. Thompson, Cheng Jiang, Geoffrey L. Hammond, David Tritchler, Martin Yaffe & Norman F. Boyd. (2004) Association between the T27C polymorphism in the cytochrome P450 c17? (CYP17) gene and risk factors for breast cancer. Breast Cancer Research and Treatment 88:3, pages 217-230.
Crossref
Crossref
A. Kistner, S. H. Jacobson, G. Celsi, M. Vanpee & K. Brismar. (2004) IGFBP-1 levels in adult women born small for gestational age suggest insulin resistance in spite of normal BMI. Journal of Internal Medicine 255:1, pages 82-88.
Crossref
Crossref
J. A. M. J. L. Janssen & S. W. J. Lamberts. 2004. Endocrine Aspects of Successful Aging: Genes, Hormones and Lifestyles. Endocrine Aspects of Successful Aging: Genes, Hormones and Lifestyles
49
61
.
Kerstin Brismar & Moira S. Lewitt. 2004. IGF and Nutrition in Health and Disease. IGF and Nutrition in Health and Disease
251
270
.
Callum LivingstoneGordon Aa Ferns. (2016) Review: Insulin-like growth factor-related proteins and diabetic complications. The British Journal of Diabetes & Vascular Disease 3:5, pages 326-331.
Crossref
Crossref
Anders Juul. (2003) Serum levels of insulin-like growth factor I and its binding proteins in health and disease. Growth Hormone & IGF Research 13:4, pages 113-170.
Crossref
Crossref
Claudia Cocca, Alicia Gutiérrez, Mariel Núñez, Máximo Croci, Gabriela Martı́n, Graciela Cricco, Elena Rivera & Rosa Bergoc. (2003) Suppression of mammary gland tumorigenesis in diabetic rats. Cancer Detection and Prevention 27:1, pages 37-46.
Crossref
Crossref
Anna‐Lena Unden, Stig Elofsson, Sarah Knox, Moira S. Lewitt & Kerstin Brismar. (2002) IGF‐I in a normal population: relation to psychosocial factors. Clinical Endocrinology 57:6, pages 793-803.
Crossref
Crossref
Eeva S. Leinonen, Jukka T. Salonen, Riitta M. Salonen, Riitta A. Koistinen, Pekka J. Leinonen, Seppo S. Sarna & Marja-Riitta Taskinen. (2002) Reduced IGFBP-1 Is Associated With Thickening of the Carotid Wall in Type 2 Diabetes. Diabetes Care 25:10, pages 1807-1812.
Crossref
Crossref
Manjinder S Sandhu, Adrian H Heald, J Martin Gibson, J Kennedy Cruickshank, David B Dunger & Nicholas J Wareham. (2002) Circulating concentrations of insulin-like growth factor-I and development of glucose intolerance: a prospective observational study. The Lancet 359:9319, pages 1740-1745.
Crossref
Crossref
Marianne Henricsson, Kerstin Berntorp, Per Fernlund & Göran Sundkvist. (2002) Progression of Retinopathy in Insulin-Treated Type 2 Diabetic Patients. Diabetes Care 25:2, pages 381-385.
Crossref
Crossref
MU Halldin, J Aman, K Brismar, I Jones, T Tuvemo & J Gustafsson. (2007) Anticholinergic treatment improves glycaemic control in adolescent girls with insulin‐dependent diabetes mellitus. Acta Paediatrica 90:4, pages 393-399.
Crossref
Crossref
Janssen & Lamberts. (2000) Circulating IGF-I and its protective role in the pathogenesis of diabetic angiopathy. Clinical Endocrinology 52:1, pages 1-9.
Crossref
Crossref
Shaodong Guo, Graham Rena, Stephen Cichy, Xiaowei He, Philip Cohen & Terry Unterman. (1999) Phosphorylation of Serine 256 by Protein Kinase B Disrupts Transactivation by FKHR and Mediates Effects of Insulin on Insulin-like Growth Factor-binding Protein-1 Promoter Activity through a Conserved Insulin Response Sequence. Journal of Biological Chemistry 274:24, pages 17184-17192.
Crossref
Crossref